Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
”Fantastic live panel discussions at the First annual Paradigms in Practice PIP now flawlessly moderated by Health care Unfiltered host Chadi Nabhan.
A true who’s‑who in oncology breaking down the latest ASCO 2026 data and what it means for patients”
Other Articles Featuring Vivek Subbiah On OncoDaily.
